Clinical Trial Update: Phase IIa Study Evaluating AZD7798 in Crohn's Disease [Phase 2]

View source ↗

Summary

Phase IIa trial of AZD7798 for moderate-to-severe Crohn's disease is ongoing, with the study currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• AZD7798 (AZD7798)

Snippet

Sponsor: AstraZeneca | Conditions: Moderate to Severe Crohn's Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING